Sie sind auf Seite 1von 7

c anticoagulant 


  
   c  

        Y Y   
   

         
     
     

c  

c     


    
   
       

oumadinsitaminantagonists)


     
  
   
    
        !  "#$%
  
      &

       
      
     
    
 '  
()*+    (,+   (c-+ 
 
  

   

dverseeffects

,  #.              
  /0
  /..  '  


                 (- 
          +

)       


         
   
   
  )  

vailableagents

Ñ &   (1 +’ YY Y   Y  


 

Ñ c   
 ’ YY   Y 
  

Ñ 2 Y   Y
Ñ ,
  





-eparinandderivativesubstances

-           !     
 !!!



   -      Y Y( 3  + Y Y
         *        
  
   

owmolecularweightheparin

[    

   

    
     
   
c,     (
     + 
  
 

ntheticpentasaccharideinhibitorsoffactora

Ñ -     
   
  ( 
  + 
  
 
 
 !   
     

  
Ñ !    

ajorpharmaceutical-eparinrecallduetocontamination

! 4 
%..#3  -       
      
      
  -       1
 
      
   '         
    
5- 
) c      
 /6 
       -   
       
,   78 1
  


   $#9  
  3    

 : c  
; <  =7,   

  
  
    
             
   
     '
  
7

irectthrombininhibitors

c 
   
 
 
 1   

              c   
 

    ( +     
- ) c   (-)c+ 
   %.."     
     -   %..>     
  
 

Xthertpesofanticoagulants

4 
      8   
?)         
    

Ñ ÿatroxobin     


   ' 
  

       (    +
Ñ -ementin       
   -   
 

oodsupplements

-    

      ;   [   

@   


             (,+   

()*+  
 (*+   
     
      
 

c   


[                   
          1
    
 c   
  
 
       

      


Ñ )c         *     



  
   !     
Ñ 1    *  !   
     
      !  
   )c
1     
     
 !   
 
   c1)
Ñ A 
 
  
  !
      (  +
 



c antihemorrhagic(antihaemorrhagic+   

 
(   +!   hemostatic(  haemostatic+
 

tptics(  stiptics+    



 
  
      3          

c 

     
    
  =

Ñ     


       
Ñ [' 
                


 


    

     
 
             

[

 
 
                   
    
      '            
     

A  

icrofibrillarcollagen

4    


(41-+           !
       
  
    
5  


   
    
     
41- 
    
   
  

       


    41-  


 !    
       
   
41-   
 
 
    
     
hitosan

1
 
     
  1
   
   
     ' 

     5  


 
      
  
 
 
    
   
   
     
1
       


      '
  
  
    
      
B C1


- 
 1
    
      
  D        E1  
tptics



  

c  
 (     
 +
   

    (
  +   


   
      
 
  2   
          
       
  
                     
    

c             
   

      
   

    

  
 



’hrombolsis
  (Y+
   !  
 Y  
  !       

   
      (,c+
   
      

c 


 
 
 

  
  
             

,c
                 ,c

   


 =

Ñ    
Ñ    
Ñ 8         
Ñ   ( ,c+
Ñ   
Ñ    
,    

-   


     (   +2   


         
    &
 

  (

  +   
F  
F
 
  
 


4
     
     

  
 '
     
(
 +
 
  3 
 
  
          

5 

)  

 =

Ñ 4    


Ñ   (
  +
Ñ 4     
Ñ c 
 

c      


     
 

  (    
     

  + %"G"#
 

   !       (  '  
+

     
    

 

!    



5   c      
   

 
  
    '    !     
 
       
 
(  +   

        1 ,     
    

c 5    ; D  ,
 
 
   
 

 
  ,,1! c


 
     

         H  

            

1    


         

 
bsolute

,             


 0 
 
   
 
0 
     
   
 0 
(   
   
 
0
  +   
    

  (I/#. I/..
+              

          



      
   

  
 '
      
     

 
elative

1            


%        
 (1,8+   
 /.